Slovenian researchers help prove benefits of DNA-adapted health treatments
Ljubljana, 3 February - A number of Slovenian doctors and researchers took part in a breakthrough international study showing that the use of medicines tailored to patients' pharmacogenetic data lowers adverse drug effects by 30%. This is the first study to prove the benefits of prescribing medicines based on patient's genetic markers.
The rest of this news item is available to subscribers.
The news item consists of 2.010 characters (without spaces) or 367 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.